盆底康复改善直肠癌术后功能结局与生活质量:FORCE随机对照试验研究方案
直肠癌低位前切除术后高达90%患者出现肛门直肠功能障碍,目前无标准化治疗。FORCE试验为多中心两臂随机对照试验,计划随机128例患者,比较标准化盆底康复与标准治疗对大便失禁、生活质量及成本效果的影响,主要终点为Wexner失禁评分。
要点
- 低位前切除术后高达90%患者出现肛门直肠功能障碍,缺乏标准化治疗。
- FORCE试验计划随机128例,比较标准化盆底康复与标准治疗。
- 主要终点为Wexner失禁评分,干预开始后3个月测量,随访1年。
核心结论
- 研究旨在验证盆底康复对直肠癌保肛术后患者大便失禁、生活质量及成本的获益优于标准治疗。
研究设计与样本
- FORCE试验为多中心、两臂随机对照试验,从参与医院招募低位前切除术后患者。
- 计划随机128例患者,分为标准治疗组或标准化盆底康复项目组。
- 按性别和是否追加放疗进行可变区组分层,无法实现最优盲法。
主要发现
- 原文为研究方案,未报告试验结果。
关键数值与推荐
- 主要终点为Wexner失禁评分,于干预开始后3个月测量,随访1年用于可持续性研究。
- 次要终点包括健康相关生活质量、大便失禁相关生活质量及成本效果。
- 基线测量在随机化前完成。
- 原文提及低位前切除术后高达90%患者出现肛门直肠功能障碍,荷兰国家医疗预算每患者每年花费超过2000欧元。
- 原文提及盆底康复治疗大便失禁的成功率为50-80%。
临床怎么用
- 若试验证实获益,盆底康复可能成为低位前切除术后大便失禁或肛门直肠功能障碍的术后照护选择。
局限性
- 无法实现最优盲法。
- 原文为研究方案,尚无结果数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: After low anterior resection (LAR), up to 90% of patients develop anorectal dysfunction. Especially fecal incontinence has a major impact on the physical, psychological, social, and emotional functioning of the patient but also on the Dutch National Healthcare budget with more than €2000 spent per patient per year. No standardized treatment is available to help these patients. Common treatment nowadays is focused on symptom relief, consisting of lifestyle advices and pharmacotherapy with bulking agents or antidiarrheal medication. Another possibility is pelvic floor rehabilitation (PFR), which is one of the most important treatments for fecal incontinence in general, with success rates of 50-80%. No strong evidence is available for the use of PFR after LAR. This study aims to prove a beneficial effect of PFR on fecal incontinence, quality of life, and costs in rectal cancer patients after sphincter-saving surgery compared to standard treatment. METHODS: The FORCE trial is a multicenter, two-armed, randomized clinical trial. All patients that underwent LAR are recruited from the participating hospitals and randomized for either standard treatment or a standardized PFR program. A total of 128 patients should be randomized. Optimal blinding is not possible. Stratification will be done in variable blocks (gender and additional radiotherapy). The primary endpoint is the Wexner incontinence score; secondary endpoints are health-related and fecal-incontinence-related QoL and cost-effectiveness. Baseline measurements take place before randomization. The primary endpoint is measured 3 months after the start of the intervention, with a 1-year follow-up for sustainability research purposes. DISCUSSION: The results of this study may substantially improve postoperative care for patients with fecal incontinence or anorectal dysfunction after LAR. This section provides insight in the decisions that were made in the organization of this trial. TRIAL REGISTRATION: Netherlands Trial Registration, NTR5469, registered on 03-09-2015. Protocol FORCE trial V18, 19-09-2019. Sponsor Radboud University Medical Center, Nijmegen.
引用
- Kalkdijk-Dijkstra AJ, van der Heijden JAG, van Westreenen HL, et al. Pelvic floor rehabilitation to improve functional outcome and quality of life after surgery for rectal cancer: study protocol for a randomized controlled trial (FORCE trial). Trials. 2020. PMID: 31992358. doi:10.1186/s13063-019-4043-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。